1,333
Participants
Start Date
April 30, 2015
Primary Completion Date
June 30, 2017
Study Completion Date
June 30, 2017
Pre-emptive screening and treatment for cryptococcal disease
Preemptive screening for cryptococcal disease among individuals with CD4 counts below 100 cells/mm3 with anti fungal therapy for those what are Cryptococcus antigen positive. These participants will be followed longitudinally for 12 months to determine clinical outcome, with their outcome compared with similar patients who are cryptococcal antigen negative, who will also be followed longitudinally for 12 months.
Parirenyatwa Hospital, Harare
Centers for Disease Control and Prevention
FED
University of Zimbabwe
OTHER